Anticancer properties of the flavone wogonin

Toxicology

Volumn 314, Issue 1, 2013, Pages 60-64

  Chirumbolo, Salvatore ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APIGENIN; BAICALEIN; CHRYSIN; LUTEOLIN; NOBILETIN; TANGERETIN; WOGONIN; ANTINEOPLASTIC AGENT; ANTIOXIDANT; FLAVANONE DERIVATIVE;

CANCER CHEMOTHERAPY; CANCER PREVENTION; CHEMOPROPHYLAXIS; DRUG MECHANISM; HUMAN; LETTER; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CHEMISTRY; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIOXIDANTS; FLAVANONES; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84884943808     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2013.08.016     Document Type: Letter

References (39)

1. Araújo J.R., Gonçalves P., Martel F. Chemopreventive effect of dietary polyphenols in colorectal cancer cell lines. Nutr. Res. 2011, 31(February (2)):77-87.
2. Artursson P., Karlsson J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 1991, 175:880-885.
3. Asensi M., Ortega A., Mena S., Feddi F., Estrela J.M. Natural polyphenols in cancer therapy. Crit. Rev. Clin. Lab. Sci. 2011, 48(September-December (5-6)):197-216.
4. Baek S.H., Kim S.M., Nam D., Lee J.H., Ahn K.S., Choi S.H., Kim S.H., Shim B.S., Chang I.M., Ahn K.S. Antimetastatic effect of nobiletin through the down-regulation of CXC chemokine receptor type 4 and matrix metallopeptidase-9. Pharm. Biol. 2012, 50(October (10)):1210-1218.
5. Brack M.E., Boterberg T., Depypere H.T., Stove C., Leclercq G., Mareel M.M. The citrus methoxyflavone tangeretin affects human cell-cell interactions. Adv. Exp. Med. Biol. 2002, 505:135-139.
6. Brandin H., Viitanen E., Myrberg O., Arvidsson A.K. Effects of herbal medicinal products and food supplements on induction of CYP1A2, CYP3A4 and MDR1 in the human colon carcinoma cell line LS180. Phytother. Res. 2007, 21(March (3)):239-244.
7. Chirumbolo S. Quercetin in cancer prevention and therapy. Integr. Cancer Ther. 2013, 12(March (2)):97-102.
8. Derenne A., Van Hemelryck V., Lamoral-Theys D., Kiss R., Goormaghtigh E. FTIR spectroscopy: a new valuable tool to classify the effects of polyphenolic compounds on cancer cells. Biochim. Biophys. Acta 2013, 1832(January (1)):46-56.
9. Guo A.J., Choi R.C., Cheung A.W., Chen V.P., Xu S.L., Dong T.T., Chen J.J., Tsim K.W. Baicalin, a flavone, induces the differentiation of cultured osteoblasts: an action via the Wnt/beta-catenin signaling pathway. J. Biol. Chem. 2011, 286(August (32)):27882-27893.
10. Gwak J., Oh J., Cho M., Bae S.K., Song I.S., Liu K.H., Jeong Y., Kim D.E., Chung Y.H., Oh S. Galangin suppresses the proliferation of β-catenin response transcription-positive cancer cells by promoting adenomatous polyposis coli/Axin/glycogen synthase kinase-3β-independent β-catenin degradation. Mol. Pharmacol. 2011, 79(June (6)):1014-1022.
11. Ha J., Zhao L., Zhao Q., Yao J., Zhu B.B., Lu N., Ke X., Yang H.Y., Li Z., You Q.D., Guo Q.L. Oroxylin A improves the sensitivity of HT-29 human colon cancer cells to 5-FU through modulation of the COX-2 signaling pathway. Biochem. Cell Biol. 2012, 90(August (4)):521-531.
12. He L., Dai Q., Zhao Y., Zhao L., Wang H., Li Z., You Q., Lu N., Guo Q. Wogonin induced G1 cell cycle arrest by regulating Wnt/β-catenin signaling pathway and inactivating CDK8 in human colorectal cancer carcinoma cells. Toxicology 2013, doi:pii: S0300-483X(13)00192-310.1016/j.tox.2013.07.013. July.
13. Huang S.T., Wang C.Y., Yang R.C., Chu C.J., Wu H.T., Pang J.H. Wogonin, an active compound in Scutellaria baicalensis, induces apoptosis and reduces telomerase activity in the HL-60 leukemia cells. Phytomedicine 2010, 17(January (1)):47-54.
14. Jin H., Leng Q., Li C. Dietary flavonoid for preventing colorectal neoplasms. Cochrane Database Syst. Rev. 2012, 8(August):CD009350.
15. Khan M.S., Halagowder D., Devaraj S.N. Methylated chrysin induces co-ordinated attenuation of the canonical Wnt and NF-kB signaling pathway and upregulates apoptotic gene expression in the early hepatocarcinogenesis rat model. Chem. Biol. Interact. 2011, 193(August (1)):12-21.
16. Kaur M., Velmurugan B., Tyagi A., Agarwal C., Singh R.P., Agarwal R. Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through down-regulation of beta-catenin-dependent signaling. Neoplasia 2010, 12(May (5)):415-424.
17. Lee D.H., Rhee J.G., Lee Y.J. Reactive oxygen species up-regulate p53 and Puma; a possible mechanism for apoptosis during combined treatment with TRAIL and wogonin. Br. J. Pharmacol. 2009, 157(August (7)):1189-1202.
18. Li T., Li N., Guo Q., Ji H., Zhao D., Xie S., Li X., Qiu Z., Han D., Chen X., You Q. Inhibitory effects of wogonin on catalytic activity of cytochrome P450 enzyme in human liver microsomes. Eur. J. Drug Metab. Pharmacokinet. 2011, 36(December (4)):249-256.
19. Liu H., Liu K., Huang Z., Park C.M., Thimmegowda N.R., Jang J.H., Ryoo I.J., He L., Kim S.O., Oi N., Lee K.W., Soung N.K., Bode A.M., Yang Y., Zhou X., Erikson R.L., Ahn J.S., Hwang J., Kim K.E., Dong Z., Kim B.Y. A chrysin derivative suppresses skin cancer growth by inhibiting cyclin-dependent kinases. J. Biol. Chem. 2013, 10.1074/jbc.M113.464669.
20. Liu J., Taylor S.F., Dupart P.S., Arnold C.L., Sridhar J., Jiang Q., Wang Y., Skripnikova E.V., Zhao M., Foroozesh M. Pyranoflavones: a group of small-molecule probes for exploring the active site cavities of cytochrome P450 enzymes 1A1, 1A2, and 1B1. J. Med. Chem. 2013, 56(May (10)):4082-4092.
21. Ozmen A., Madlener S., Bauer S., Krasteva S., Vonach C., Giessrigl B., Gridling M., Viola K., Stark N., Saiko P., Michel B., Fritzer-Szekeres M., Szekeres T., Askin-Celik T., Krenn L., Krupitza G. In vitro anti-leukemic activity of the ethno-pharmacological plant Scutellaria orientalis ssp. carica endemic to western Turkey. Phytomedicine 2010, 17(January (1)):55-62.
22. Romagnolo D.F., Selmin O.I. Flavonoids and cancer prevention: a review of the evidence. J. Nutr. Gerontol. Geriatr. 2012, 31(3):206-238.
23. Samarghandian S., Afshari J.T., Davoodi S. Chrysin reduces proliferation and induces apoptosis in the human prostate cancer cell line pc-3. Clinics (Sao Paulo) 2011, 66(6):1073-1079.
24. Saud S.M., Young M.R., Jones-Hall Y.L., Ileva L., Evbuomwan M.O., Wise J., Colburn N.H., Kim Y.S., Bobe G. Chemopreventive activity of plant flavonoid isorhamnetin in colorectal cancer is mediated by oncogenic Src and β-catenin. Cancer Res. 2013, 10.1158/0008-5472.CAN-13-0525.
25. Sergeev I.N., Li S., Colby J., Ho C.T., Dushenkov S. Polymethoxylated flavones induce Ca(2+)-mediated apoptosis in breast cancer cells. Life Sci. 2006, 80(December (3)):245-253.
26. Shao Y.X., Zhao P., Li Z., Liu M., Liu P., Huang M., Luo H.B. The molecular basis for the inhibition of human cytochrome P450 1A2 by oroxylin and wogonin. Eur. Biophys. J. 2012, 41(March (3)):297-306.
27. Shi M.D., Liao Y.C., Shih Y.W., Tsai L.Y. Nobiletin attenuates metastasis via both ERK and PI3K/Akt pathways in HGF-treated liver cancer HepG2 cells. Phytomedicine 2013, 20(June (8-9)):743-752.
28. Sun L.P., Chen A.L., Hung H.C., Chien Y.H., Huang J.S., Huang C.Y., Chen Y.W., Chen C.N. Chrysin: a histone deacetylase 8 inhibitor with anticancer activity and a suitable candidate for the standardization of Chinese propolis. J Agric Food Chem. 2012, 60(47):11748-11758.
29. Tan K.Y., Liu C.B., Chen A.H., Ding Y.J., Jin H.Y., Seow-Choen F. The role of traditional Chinese medicine in colorectal cancer treatment. Tech. Coloproctol. 2008, 12(March (1)):1-6. (discussion 6. doi: 10.1007/s10151-008-0392-z).
30. Tao L., Zhu Y.J., Lu X.M., Gu Y., Zhao A.G., Zheng J., Fu C.G., Yang J.K. Clinical study on survival benefit for elderly patients with resected stage II or III colorectal cancer based on traditional Chinese medicine syndrome differentiation and treatment. Zhong Xi Yi Jie He Xue Bao 2010, 8(December (12)):1159-1164.
31. Ueng Y.F., Shyu C.C., Lin Y.L., Park S.S., Liao J.F., Chen C.F. Effects of baicalein and wogonin on drug-metabolizing enzymes in C57BL/6J mice. Life Sci. 2000, 67(September (18)):2189-2200.
32. Yang Y.F., GE J.Z., Wu Y., Xu Y., Liang B.Y., Luo L., Wu X.W., Liu D.Q., Zhang X., Song F.X., Geng Z.Y. Cohort study on the effect of a combined treatment of traditional Chinese medicine and Western medicine on the relapse and metastasis of 222 patients with stage II and III colorectal cancer after radical operation. Chin. J. Integr. Med. 2008, 14(December (4)):251-256.
33. Yeh C.C., Sung F.C., Tang R., Chang-Chieh C.R., Hsieh L.L. Polymorphisms of cytochrome P450 1A2 and N-acetyltransferase genes, meat consumption, and risk of colorectal cancer. Dis. Colon Rectum 2009, 52(January (1)):104-111.
34. Walle T. Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass?. Semin. Cancer Biol. 2007, 17(October (5)):354-362.
35. Wang E., Bussom S., Chen J., Quinn C., Bedognetti D., Lam W., Guan F., Jiang Z., Mark Y., Zhao Y., Stroncek D.F., White J., Marincola F.M., Cheng Y.C. Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment. BMC Med. Genomics 2011, 4(May):38.
36. Wang Y., Zhang Y., Qian C., Cai M., Li Y., Li Z., You Q., Hu R., Guo Q. GSK3β/β-catenin signaling is correlated with the differentiation of glioma cells induced by wogonin. Toxicol Lett. 2013, doi:pii: S0378-4274(13)01137-5. 10.1016/j.toxlet.2013.07.013. July.
37. Woziwodzka A., Tarasewicz M., Piosik J. Heterocyclic aromatic amines, food-derived mutagens: metabolism and relevance to cancer susceptibility. Postepy Biochem. 2010, 56(4):435-446.
38. Zhang Y., Li Q., Zhou D., Chen H. Genistein, a soya isoflavone, prevents azoxymethane-induced up-regulation of WNT/β-catenin signalling and reduces colon pre-neoplasia in rats. Br. J. Nutr. 2013, 109(January (1)):33-42.
39. Zhao Y., Fang X., Wang Y., Zhang J., Jiang S., Liu Z., Ma Z., Xu L., Li E., Zhang K. Comprehensive analysis for histone acetylation of human colon cancer cells treated with a novel HDAC inhibitor. Curr. Pharm. Des. 2013, (in press). July.